|
A Message from Huge Alerts
 
Two massive multi-billion-dollar markets for its regenerative therapies position this company as one of the most promising up-and-coming medtech stocks on Wall Street!
The medtech arena is not the easiest to navigate given how many kinds of companies are in it. It’s all about finding emerging players like this underfollowed company which has astronomical growth potential. Zack’s Small Cap Research recently increased its price target on the stock to $9.25! This notable research firm sees the VALUE!
According to Zack’s report, the company is “still underpriced even after its recent move higher and continues to represent a good opportunity at recent prices for investors to get in before what we believe will be a more aggressive move higher in the not-too-distant future. The vision management has for the company’s product and the focus they are using to deliver results are encouraging and are now being rewarded by increased demand.” These optimistic comments and bullish price target came shortly after the company reported explosive Q3 earnings that beat expectations.
See why this little-known medtech company could see a major upside in the near future! |
